Theravance Biopharma, Inc. (TBPH)
17.02
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
17.02
0.00 (0.00%)
After-Hours: 16:29
Theravance Biopharma Gross Profit (TTM) : 98.52M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.52M |
| March 31, 2026 | 104.08M |
| December 31, 2025 | 101.82M |
| September 30, 2025 | 74.83M |
| June 30, 2025 | 71.55M |
| March 31, 2025 | 59.41M |
| December 31, 2024 | 58.37M |
| September 30, 2024 | 56.82M |
| June 30, 2024 | 55.87M |
| March 31, 2024 | 55.58M |
| December 31, 2023 | 51.37M |
| September 30, 2023 | 48.93M |
| June 30, 2023 | 45.40M |
| March 31, 2023 | 42.10M |
| December 31, 2022 | 45.21M |
| September 30, 2022 | 45.73M |
| June 30, 2022 | 45.46M |
| March 31, 2022 | 36.36M |
| December 31, 2021 | 24.48M |
| September 30, 2021 | 10.56M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 3.036M |
| September 30, 2019 | 17.28M |
| June 30, 2019 | 28.80M |
| March 31, 2019 | 52.93M |
| December 31, 2018 | 56.94M |
| September 30, 2018 | 44.09M |
| June 30, 2018 | 35.87M |
| March 31, 2018 | 13.88M |
| December 31, 2017 | 8.814M |
| September 30, 2017 | 11.37M |
| June 30, 2017 | 26.04M |
| March 31, 2017 | 28.72M |
| December 31, 2016 | 44.38M |
| September 30, 2016 | 41.11M |
| June 30, 2016 | 32.92M |
| March 31, 2016 | 34.41M |
| December 31, 2015 | 36.52M |
| September 30, 2015 | 34.04M |
| June 30, 2015 | 29.17M |
| March 31, 2015 | 24.85M |
| December 31, 2014 | 5.137M |
| September 30, 2014 | 6.407M |
| June 30, 2014 | 0.982M |
| March 31, 2014 | -1.027M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Zymeworks, Inc. | 28.05M |
| Viatris, Inc. | 5.838B |
| Ocular Therapeutix, Inc. | 45.35M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |